AI assistant
Sending…
Milestone Pharmaceuticals Inc. — Director's Dealing 2019
Sep 11, 2019
9643_dirs_2019-09-11_a4dc1326-f9e3-4dab-9497-94c26f21c40f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Milestone Pharmaceuticals Inc. (MIST)
CIK: 0001408443
Period of Report: 2019-09-09
Reporting Person: Hasija Amit (CFO & EVP of Corp. Development)
More from Milestone Pharmaceuticals Inc.
Capital/Financing Update
2026
May 13
Report Publication Announcement
2026
May 13
Interim / Quarterly Report
2026
May 13
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 20
Annual Report
2026
Mar 20
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5